References
- Prockop D J, Kivirikko K I, Tuderman L, Guzman N A. The biosynthesis of collagen and its disorders. N Engl J Med 1979; 301: 13–23
- Fessler J H, Fessler L I. Biosynthesis of procollagen. Ann Rev Biochem 1978; 47: 129–62
- Risteli L, Risteli J. Noninvasive methods for detection of organ fibrosis. Connective tissue in health and disease, M Rojkind. CRC Press, Boca Raton, Florida 1990; 61–98
- Hørslev-Petersen K, Bentsen K D, Junker P, Lorenzen I. Serum amino-terminal type III procollagen peptide in rheumatoid arthritis. Relationship to disease activity, treatment, and development of joint erosions. Arthr Rheum 1986; 29: 592–9
- Haukipuro K, Risteli L, Kairaluoma M I, Risteli J. Aminoterminal propeptide of type III procollagen in healing wound in humans. Ann Surg 1987; 206: 752–6
- Hørslev-Petersen K, Kim K Y, Pedersen L R, Bentsen K D, Uldbjerg N, Oxlund H, et al. Serum aminoterminal type III procollagen peptide. Relationship to biosynthesis of collagen type III in experimentally induced granulation tissue in rats. APMIS 1988; 96: 793–804
- Stoltenberg M, Hansen M, Hørslev-Petersen K, Lorenzen I. The aminoterminal propeptide of collagen type III in rheumatoid arthritis. Pulse treatment with methylprednisolone [abstract]. Br J Rheumatol 1992; 31: 129, Suppl 2
- Oikarinen A, Autio P, Vuori J, Väänänen K, Risteli L, Kiistala U, et al. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 1992; 126: 172–8
- Bentsen K D, Henriksen J H, Bendtsen F, Hørslev-Petersen K, Lorenzen I. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology 1990; 11: 957–63
- Bentsen K D, Henriksen J H, Boesby S, Hørslev-Petersen K, Lorenzen I. Hepatic and renal extraction of circulating type III procollagen aminoterminal propeptide and hyaluronan in pig. J Hepatol 1989; 9: 177–83
- Smedsrød B. Aminoterminal propeptide of type III procollagen is cleared from the the circulation by receptor-mediated endocytosis in liver endothelial cells. Coll Rel Res 1988; 8: 375–88
- Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8
- Jensen L T, Risteli J, Nielsen M D, Henriksen J H, Olesen H P, Risteli L, et al. Purification of porcine aminoterminal propeptide of type III procollagen from lymph and use for lymphatic clearance studies in pigs. Matrix 1992; 11: 73–9
- Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrød B. Clearance of NH2-terminal propeptides of type I and III procollagen is a physiological function of the scavenger in liver endothelial cells. J Exp Med 1994; 179: 405–12
- Swartz S L, Dluhy R G. Corticosteroids: Clinical pharmacology and therapeutic use. Drugs 1978; 16: 238–55
- Peck W A, Brandt J, Miller I. Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro. Proc Nat Acad Sci USA 1967; 57: 1599–606
- Shull S, Cutroneo K R. Glucocorticoids coordinately regulate procollagens type I and type III synthesis. J Biol Chem 1983; 258: 3364–9
- Lems W E, Jacobs J WG, Brink H R, Rijn H JM, Bijlsma J WJ. Transient decrease in osteocalcin and markers of type I collagen turnover during high-dose corticosteroid pulse therapy in rheumatoid arthritis. Br J Rheumatol 1993; 32: 787–9